A partnership with the Cleveland Clinic has prompted a four-year-old biotech startup to relocate its headquarters to Cleveland from Durham, NC, one of the points of the Research Triangle. However, Lamassu Pharma, LLC, has yet to identify the location of its offices. The small firm hopefully will one day grow into a force for positive change in the pharmaceutical industry.
Privately held Lamassu Pharma, doing business as Lamassu Biotech, has been making strides toward new cancer therapies that could transform oncology practices and the treatment of cancers that presently do not respond to treatment. In addition to the Cleveland Clinic, the company’s strategic partners include the Mayo Clinic as well as McGill University and the National Cancer Center, among others.